Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States

Neuro-Oncology

Volumn 17, Issue 8, 2015, Pages 1166-1173

  Kshettry, Varun R ^a   Ostrom, Quinn T ^b,c   Kruchko, Carol ^b,c   Al Mefty, Ossama ^d   Barnett, Gene H ^a   Barnholtz Sloan, Jill S ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Mission Officer of the Central Brain Tumor Registry of the United States   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anaplastic; Atypical; Epidemiology; Malignant; Meningioma

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASIAN; BLACK PERSON; BRAIN HEMANGIOMA; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CHILD; ETHNICITY; FEMALE; HISPANIC; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PACIFIC ISLANDER; PRESCHOOL CHILD; RACE DIFFERENCE; SCHOOL CHILD; SEX RATIO; UNITED STATES; VERY ELDERLY; YOUNG ADULT; INCIDENCE; MENINGIOMA; NEWBORN; PATHOLOGY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGIOMA; MIDDLE AGED; NEOPLASM GRADING; UNITED STATES; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84943245009     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov069     Document Type: Article

References (37)

1. Claus EB, Bondy ML, Schildkraut JM, et al. Epidemiology of intracranial meningioma. Neurosurgery. 2005;57(6):1088-1095. discussion 1088-1095.
2. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15(Suppl 2): ii1-i56.
3. Combs SE, Schulz-Ertner D, Debus J, et al. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Int J Radiat Oncol Biol Phys. 2011;81(5):1415-1421.
4. Krayenbuhl N, Pravdenkova S, Al-Mefty O. De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome. Neurosurgery. 2007;61(3):495-503, discussion 503-494.
5. Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery. 2005;57(3): 538-550. discussion 538-550.
6. Pasquier D, Bijmolt S, Veninga T, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2008;71(5):1388-1393.
7. Perry A, Scheithauer BW, Stafford SL, et al. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999;85(9):2046-2056.
8. Mahmood A, Caccamo DV, Tomecek FJ, et al. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery. 1993; 33(6):955-963.
9. Rohringer M, Sutherland GR, Louw DF, et al. Incidence and clinicopathological features of meningioma. J Neurosurg. 1989; 71(5 Pt 1):665-672.
10. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. 2nd ed. Berlin: Springer-Verlag; 1993.
11. Kleihues P, Cavenee WK. Pathology and Genetics of Tumours of the Central Nervous System. 2nd ed. Lyon: IARC Press; 2000.
12. McLean CA, Jolley D, Cukier E, et al. Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology. 1993;23(4):349-353.
13. Perry A, Stafford SL, Scheithauer BW, et al. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997; 21(12):1455-1465.
14. Yang SY, Park CK, Park SH, et al. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry. 2008;79(5):574-580.
15. Percy C, Fritz A, Jack A, et al. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva: World Health Organization; 2000.
16. Surawicz TS, McCarthy BJ, Jukich PJ, et al. The accuracy and completeness of primary brain and central nervous system tumor data: results from the Central Brain Tumor Registry of the United States. J Registry Manage. 2000;27(2):51-56.
17. Goyal LK, Suh JH, Mohan DS, et al. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys. 2000;46(1):57-61.
18. Kallio M, Sankila R, Hakulinen T, et al. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery. 1992;31(1):2-12.
19. Dobes M, Khurana VG, Shadbolt B, et al. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000-2008): Findings of a multicenter Australian study. Surg Neurol Int. 2011;2:176.
20. Backer-Grondahl T, Moen BH, Torp SH. The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol. 2012; 5(3):231-242.
21. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
22. Deltour I, Johansen C, Auvinen A, et al. Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst. 2009;101(24):1721-1724.
23. Klaeboe L, Lonn S, Scheie D, et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer. 2005;117(6):996-1001.
24. Morris Z, Whiteley WN, Longstreth WT Jr., et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.
25. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18): 1821-1828.
26. Preston-Martin S, Staples M, Farrugia H, et al. Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982-1990: patterns of incidence and survival. Neuroepidemiology. 1993;12(5):270-279.
27. Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol. 2008;26(2):279-282.
28. Jhawar BS, Fuchs CS, Colditz GA, et al. Sex steroid hormone exposures and risk for meningioma. J Neurosurg. 2003;99(5): 848-853.
29. Korhonen K, Auvinen A, Lyytinen H, et al. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland. Am J Epidemiol. 2012;175(4):309-314.
30. Schlehofer B, Blettner M, Wahrendorf J. Association between brain tumors and menopausal status. J Natl Cancer Inst. 1992;84(17): 1346-1349.
31. Carroll RS, Zhang J, Black PM. Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol. 1999; 42(2):109-116.
32. McCarthy BJ, Kruchko C, Dolecek TA. The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends. J Reg Manage. 2013; 40(1):32-35.
33. Adegbite AB, Khan MI, Paine KW, et al. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg. 1983;58(1):51-56.
34. Al-Mefty O, Kadri PA, Pravdenkova S, et al. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg. 2004;101(2):210-218.
35. Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol. 1986;25(3):233-242.
36. Sanai N, Sughrue ME, Shangari G, et al. Risk profile associated with convexity meningioma resection in the modern neurosurgical era. J Neurosurg. 2010;112(5):913-919.
37. Wong G, Harper C. Atypical meningiomas: clinical pathological correlation. Aust N Z J Surg. 1984;54(4):331-336.